Aclaris Therapeutics, Inc.
2021 Q3 - 2026 Q1 (11 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2026 Q1 | 5/15/2026 | 19 | 0.0% | 5,006 | 3/31/2026 |
| 2023 Q4 | 1/30/2024 | 46 | 0.0% | 43,784 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 139 | 0.0% | 20,317 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 148 | 0.0% | 14,243 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 79 | 0.0% | 9,759 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 154 | 0.0% | 9,759 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 118 | 0.0% | 7,501 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 105 | 0.0% | 7,501 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 129 | 0.0% | 7,501 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 109 | 0.0% | 7,501 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 58 | 0.0% | 3,211 | 9/30/2021 |